Opioids and cannabis are primarily used as analgesics. Both function remarkably well for relieving chronic pain. Since the start of medical cannabis programs in states across the U.S. and Canada, statistics show that patients prefer the use of cannabis to opioids. This caused a 40% reduction in the use of opioids
Due to this shift in paradigm, the DEA was forced to shift their stance on certain drugs. First with cannabis and now with psychedelics. The public had to twist the arm of the government in order to have them say, “Sure we’re thinking about making it easier to research…just give us time!”
Since 1971, a single facility at the University of Mississippi has been in charge of producing cannabis plants for research purposes at the federal level. This monopoly prevented other facilities (public and private-owned) from growing marijuana for experimental reasons. In 2016, the DEA began to remove the monopoly on marijuana for medical research. Finally, they achieved what they set out to do in May 2021. The applications of several cannabis companies were approved by mid-2021. Groff Hemplex and the Biopharmaceutical Research Company revealed that they have been fully registered in the DEA database and have started cultivating cannabis plants. The first phase of harvest, which started about a month ago, will be forwarded to research facilities. Marijuana researchers across the country have commended this development.
Marijuana Moment write A top federal drug official says the “train has left the station” on psychedelics. National Institute on Drug Abuse (NIDA) Director Nora Volkow said people are going to keep using substances such as psilocybin—especially as the reform movement expands and there’s increased attention being drawn to the potential therapeutic benefits—and so researchers […]
There are tons of theories of evolution that attempt to explain how we went from single-celled organisms to the highly complicated structures we are today. I’m not getting into that entire process, but instead, am focusing on the more recent changeover from early cave-dwelling humans to the 21st century beings we are today. What happened […]
It’s been a whirlwind rise for psychedelics in general in the past few years, with tons of research into medical properties, and new legal policies being set in different parts of the country to allow medical use, or decriminalize recreational use. What’s in store for this class of drugs? Here are my 2022 predictions for […]
Appetite stimulation: HIV patients tend to lose a significant amount of their body weight because of the loss of appetite. Tetrahydrocannabinol (THC), the psychoactive compound in the plant, is famous for its hunger-inducing properties and is widely used by many people to promote weight gain for healing, such as those who are in treatment for cancer. In addition, a 2005 survey of 253 HIV-positive patients revealed that 27% of respondents were using cannabis to treat those conditions, while 97% of them said that it was beneficial in improving their appetite.
The content of THC in weed depends commonly amongst the various strains of marijuana and other products manufactured from marijuana. The same thing applies...